Growth and growth hormone in Turner syndrome: Looking back, looking ahead

Evan Los, Ronald (Ron) Rosenfeld

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Short stature is the most ubiquitous feature of Turner syndrome (TS). Today, many girls with TS are treated with recombinant human growth hormone (GH) to accelerate growth in childhood and to improve adult height. Here, we will review the history of our understanding of growth in TS, reflect on the path of clinical trials ultimately leading to regulatory approval for clinical use of GH, discuss factors associated with growth outcomes and survey the current unanswered questions about growth and GH in TS.

Original languageEnglish (US)
Pages (from-to)86-90
Number of pages5
JournalAmerican Journal of Medical Genetics, Part C: Seminars in Medical Genetics
Volume181
Issue number1
DOIs
StatePublished - Mar 1 2019

Fingerprint

Turner Syndrome
Growth Hormone
Growth
Human Growth Hormone
History
Clinical Trials

Keywords

  • growth
  • growth hormone
  • Turner syndrome

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Growth and growth hormone in Turner syndrome : Looking back, looking ahead. / Los, Evan; Rosenfeld, Ronald (Ron).

In: American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, Vol. 181, No. 1, 01.03.2019, p. 86-90.

Research output: Contribution to journalReview article

@article{ebee138543224c6288921c51f69c6992,
title = "Growth and growth hormone in Turner syndrome: Looking back, looking ahead",
abstract = "Short stature is the most ubiquitous feature of Turner syndrome (TS). Today, many girls with TS are treated with recombinant human growth hormone (GH) to accelerate growth in childhood and to improve adult height. Here, we will review the history of our understanding of growth in TS, reflect on the path of clinical trials ultimately leading to regulatory approval for clinical use of GH, discuss factors associated with growth outcomes and survey the current unanswered questions about growth and GH in TS.",
keywords = "growth, growth hormone, Turner syndrome",
author = "Evan Los and Rosenfeld, {Ronald (Ron)}",
year = "2019",
month = "3",
day = "1",
doi = "10.1002/ajmg.c.31680",
language = "English (US)",
volume = "181",
pages = "86--90",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Growth and growth hormone in Turner syndrome

T2 - Looking back, looking ahead

AU - Los, Evan

AU - Rosenfeld, Ronald (Ron)

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Short stature is the most ubiquitous feature of Turner syndrome (TS). Today, many girls with TS are treated with recombinant human growth hormone (GH) to accelerate growth in childhood and to improve adult height. Here, we will review the history of our understanding of growth in TS, reflect on the path of clinical trials ultimately leading to regulatory approval for clinical use of GH, discuss factors associated with growth outcomes and survey the current unanswered questions about growth and GH in TS.

AB - Short stature is the most ubiquitous feature of Turner syndrome (TS). Today, many girls with TS are treated with recombinant human growth hormone (GH) to accelerate growth in childhood and to improve adult height. Here, we will review the history of our understanding of growth in TS, reflect on the path of clinical trials ultimately leading to regulatory approval for clinical use of GH, discuss factors associated with growth outcomes and survey the current unanswered questions about growth and GH in TS.

KW - growth

KW - growth hormone

KW - Turner syndrome

UR - http://www.scopus.com/inward/record.url?scp=85062347698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062347698&partnerID=8YFLogxK

U2 - 10.1002/ajmg.c.31680

DO - 10.1002/ajmg.c.31680

M3 - Review article

C2 - 30811776

AN - SCOPUS:85062347698

VL - 181

SP - 86

EP - 90

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 1

ER -